Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Reading
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Reading, PA

Studies commonly pay $75 to $4,500 per completed study

267 clinical trials are currently recruiting participants within 30 miles of Reading. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

267studies recruiting
2+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Reading right now

Top 25 of 267 recruiting studies, sorted by proximity — each links to its official registry page

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Lancaster General Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Oligometastatic Breast Carcinoma, Breast Cancer Phase 2 Interventional 46 participants sought
Lehigh Valley Health Network (Data Collection Only) — Allentown, Pennsylvania (29.5 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT05534438)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,500 participants sought
Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1, Narcolepsy Type 2 Phase 2, Phase 3 Interventional 786 participants sought
Alkermes Investigational Site — Wyomissing, Pennsylvania (2.2 mi) · Sponsor: Alkermes, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06767683)

Foundational Programs to Combat Clinician Stress

Burnout, Professional, Stress, Psychological N/A Interventional 180 participants sought
Penn Medicine Lancaster General Health — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Lancaster General Hospital
See eligibility & contact on ClinicalTrials.gov (NCT07220421)

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain Tumor, Recurrent, Brain Tumor N/A Observational 600 participants sought
St Luke's University Health, Sacred Heart Campus — Allentown, Pennsylvania (29.5 mi) · Sponsor: GT Medical Technologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04427384)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Geisinger Cancer Services-Pottsville — Pottsville, Pennsylvania (27.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

Comparing Direct vs Indirect Methods for Cascade Screening

Long QT Syndrome, Familial Hypercholesterolemia N/A Interventional 200 participants sought
University of Maryland Amish Research Clinic — Lancaster, Pennsylvania (28.9 mi) · Sponsor: University of Maryland, Baltimore
See eligibility & contact on ClinicalTrials.gov (NCT05348564)

Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes

Diabetes Mellitus, Type 2, Diabetes Education N/A Interventional 65 participants sought
Reading Hospital, an affiliate of Tower Health — West Reading, Pennsylvania (1.2 mi) · Sponsor: The Reading Hospital and Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT05893927)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06532279)

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Non-small Cell Lung Cancer Phase 3 Interventional 1,000 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06561386)

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Colorectal Cancer Phase 2 Interventional 120 participants sought
UPenn Lancaster-Ann B. Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Criterium, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06992258)

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

Knee Osteoarthritis Phase 3 Interventional 300 participants sought
Lehigh Center for Clinical Research — Allentown, Pennsylvania (29.5 mi) · Sponsor: Doron Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07219771)

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Migraine Phase 3 Interventional 1,800 participants sought
Lehigh Center for Clinical Research — Allentown, Pennsylvania (29.5 mi) · Sponsor: TriGemX Bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07645924)

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (29.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03959085)

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Phase 3 Interventional 250 participants sought
Keystone Urology Specialists — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Ferring Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06545955)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Endometrial Cancer, Endometrioid Adenocarcinoma N/A Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (29.5 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT04291612)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic Arthritis Phase 3 Interventional 1,088 participants sought
PA Regional Center for Arthritis and Osteoporosis Research — Wyomissing, Pennsylvania (2.2 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06671483)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (29.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought
Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04628767)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Geisinger Cancer Services-Pottsville — Pottsville, Pennsylvania (27.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05080673)
Actively enrolling

Studies you may be able to join near Reading

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Reading

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research Center-Reading

2760 Century Blvd #3, Reading, PA 19610
(610) 375-2466

Lehigh Center for Clinical Research

★ 5.0
1245 S Cedar Crest Blvd, Allentown, PA 18103
(610) 820-0342
"Staff was very friendly and explained information to me in great detail"
— Virgilio Baello, 5★

Clinical trials in Reading: what's recruiting

The Reading area currently has 267 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Reading, the most active research areas are:

  • Cancer & Oncology16 studies
  • Immune & Skin2 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Reading, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Reading

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Reading participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Reading pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Reading?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Reading safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Reading, PA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Reading?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Reading

Other metros within reach

Lancaster, PA428 Allentown, PA224 Philadelphia, PA2,167 York, PA446 Harrisburg, PA403 Scranton, PA96 Trenton, NJ2,341 Baltimore, MD1,646

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Reading Chronic Kidney Disease (HealthMatch) in Reading Bladder Issues Due To Spinal Cord Injury in Reading All conditions

More of PA

Philadelphia2,167 Pittsburgh1,245 York446 Lancaster428 Harrisburg403 Allentown224 Scranton96 Erie92

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts